Год
2023
-
Donanemab Shows Greater Ability to Clear Amyloid Plaque Than Aducanumab
-
EU launches AI-powered real-world data project for cancer therapies
-
FDA Approves First Fecal Transplant Therapy
-
Addressing Unmet Needs of Dementia With Lewy Bodies
-
X4 Pharmaceuticals announces positive top-line results for WHIM Syndrome drug
-
ANANDA Scientific announces FDA approval of the IND for a clinical trial exploring treatment of Social Anxiety Disorder (SAD)
-
Invitrx Draws Warning Letter for Unapproved Products
-
AXS-05 Meets Primary End Point in Phase 3 Trial of Alzheimer Agitation
-
Full-Life Technologies Acquires Focus-X Therapeutics
-
FDA Delays Decision Date on Gamida Cell BLA